Success Metrics

Clinical Success Rate
96.7%

Based on 87 completed trials

Completion Rate
97%(87/90)
Active Trials
3(3%)
Results Posted
70%(61 trials)
Terminated
3(3%)

Phase Distribution

Ph not_applicable
8
7%
Ph phase_3
29
27%
Ph phase_4
18
17%
Ph phase_2
10
9%
Ph phase_1
40
37%

Phase Distribution

40

Early Stage

10

Mid Stage

47

Late Stage

Phase Distribution105 total trials
Phase 1Safety & dosage
40(38.1%)
Phase 2Efficacy & side effects
10(9.5%)
Phase 3Large-scale testing
29(27.6%)
Phase 4Post-market surveillance
18(17.1%)
N/ANon-phased studies
8(7.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.0%

87 of 100 finished

Non-Completion Rate

13.0%

13 ended early

Currently Active

3

trials recruiting

Total Trials

107

all time

Status Distribution
Active(3)
Completed(87)
Terminated(13)
Other(4)

Detailed Status

Completed87
Withdrawn10
unknown4
Terminated3
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
107
Active
3
Success Rate
96.7%
Most Advanced
Phase 4

Trials by Phase

Phase 140 (38.1%)
Phase 210 (9.5%)
Phase 329 (27.6%)
Phase 418 (17.1%)
N/A8 (7.6%)

Trials by Status

withdrawn109%
active_not_recruiting11%
unknown44%
recruiting22%
completed8781%
terminated33%

Recent Activity

Clinical Trials (107)

Showing 20 of 107 trialsScroll for more
NCT07109245Phase 4

Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?

Recruiting
NCT06280703Phase 1

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Recruiting
NCT07282054Phase 3

Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

Completed
NCT04124302Phase 4

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

Completed
NCT05893797Not Applicable

A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Completed
NCT03229850Not Applicable

Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique

Withdrawn
NCT06931041Phase 3

Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye: A Randomized Clinical Trial

Active Not Recruiting
NCT03660553Phase 4

Simplified Insulin Regimen for the Elderly

Terminated
NCT04019821Phase 4

Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

Completed
NCT03952130Phase 3

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

Completed
NCT03248271

Effects of Insulin on Hypotension and Sarcopenia

Withdrawn
NCT04816890Phase 2

A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)

Completed
NCT01613807Phase 4

Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes

Completed
NCT03952143Phase 3

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Completed
NCT03740919Phase 3

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

Completed
NCT04049123Phase 1

A Study of LY900014 in Healthy Chinese Participants

Completed
NCT04276207Phase 1

A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

Completed
NCT03338023Phase 3

A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus

Completed
NCT02971228Phase 2

Feasibility Trial Testing the Bionic Pancreas With ZP4207

Completed
NCT03830281Phase 3

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
107